59477-37-1

Basic information

• Product Name: 3-Cyclohexen-1-amine,4-methyl-(9CI)
• Synonyms: 3-Cyclohexen-1-amine,4-methyl-(9CI);1-amino-4-methylcyclohex-3-ene
• CAS NO: 59477-37-1
• Molecular Formula: C₇H₁₃N
• Molecular Weight: 111.18482
• Product Categories: VARIOUSAMINE
• Mol File: 59477-37-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Cyclohexen-1-amine,4-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Cyclohexen-1-amine,4-methyl-(9CI)(59477-37-1)
• EPA Substance Registry System: 3-Cyclohexen-1-amine,4-methyl-(9CI)(59477-37-1)

Safety Data

• Hazardous Substances Data: 59477-37-1(Hazardous Substances Data)

Upstream product

• 177906-46-6 (1s,4s)-4-amino-1-methylcyclohexan-1-ol 
• 4736-22-5 4-methylcyclohex-3-enecarboxamide 
• 6493-79-4 methyl 4-methyl-3-cyclohexene-1-carboxylate 
• 4342-60-3 4-methylcyclohex-3-enecarboxylic acid 
• 25577-22-4 N-(4-methyl-cyclohex-3-enyl)-phthalimide 

Downstream Products

• 291756-09-7 tert-butyl (4-methylcyclohex-3-en-1-yl)carbamate 
• 1403864-55-0 tert-butyl 3-hydroxy-4-methylcyclohexylcarbamate 

Relevant articles and documents

METHODS OF SYNTHESIS OF (1R,2R,5R)-5-AMINO-2-METHYLCYCLOHEXANOL HYDROCHLORIDE AND INTERMEDIATES USEFUL THEREIN

Provided herein are methods and intermediates for making (lR,2R,5R)-5-amino-2- methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathwa

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE

Provided herein are formulations, processes, solid forms and methods of use relating to 2- (tert-butylamino)-4-((lR,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5- carboxamide.

SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Amide compounds for the potentiation of cholinergic activity

Amide compounds of the formula: wherein R1 and R2 are taken together to form lower alkenylene, etc., R3 is aryl, etc., X is N, etc., Y is a single bond, etc., and Q is ?and salt thereof, which are useful as medicament.